Review
Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management
Efectos cutáneos adversos de los nuevos tratamientos para melanoma: Clasificación y Tratamiento
Leído
9860
Vecesse ha leído el artículo
3463
Total PDF
6397
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 22 | 8 | 30 |
| 2025 5 | 170 | 34 | 204 |
| 2025 4 | 146 | 20 | 166 |
| 2025 3 | 133 | 32 | 165 |
| 2025 2 | 112 | 40 | 152 |
| 2025 1 | 93 | 41 | 134 |
| 2024 12 | 90 | 32 | 122 |
| 2024 11 | 91 | 67 | 158 |
| 2024 10 | 81 | 48 | 129 |
| 2024 9 | 58 | 31 | 89 |
| 2024 8 | 134 | 53 | 187 |
| 2024 7 | 81 | 39 | 120 |
| 2024 6 | 106 | 76 | 182 |
| 2024 5 | 72 | 53 | 125 |
| 2024 4 | 92 | 39 | 131 |
| 2024 3 | 72 | 43 | 115 |
| 2024 2 | 63 | 45 | 108 |
| 2024 1 | 89 | 50 | 139 |
| 2023 12 | 62 | 17 | 79 |
| 2023 11 | 102 | 40 | 142 |
| 2023 10 | 91 | 64 | 155 |
| 2023 9 | 69 | 36 | 105 |
| 2023 8 | 54 | 25 | 79 |
| 2023 7 | 85 | 46 | 131 |
| 2023 6 | 82 | 25 | 107 |
| 2023 5 | 60 | 24 | 84 |
| 2023 4 | 53 | 30 | 83 |
| 2023 3 | 79 | 27 | 106 |
| 2023 2 | 105 | 28 | 133 |
| 2022 1 | 58 | 23 | 81 |
| 2022 12 | 94 | 33 | 127 |
| 2022 11 | 63 | 42 | 105 |
| 2022 10 | 82 | 34 | 116 |
| 2022 9 | 63 | 43 | 106 |
| 2022 8 | 81 | 52 | 133 |
| 2022 7 | 55 | 45 | 100 |
| 2022 6 | 87 | 36 | 123 |
| 2022 5 | 79 | 63 | 142 |
| 2022 4 | 54 | 39 | 93 |
| 2022 3 | 75 | 78 | 153 |
| 2022 2 | 104 | 48 | 152 |
| 2021 1 | 92 | 62 | 154 |
| 2021 12 | 76 | 56 | 132 |
| 2021 11 | 88 | 69 | 157 |
| 2021 10 | 113 | 82 | 195 |
| 2021 9 | 50 | 56 | 106 |
| 2021 8 | 83 | 49 | 132 |
| 2021 7 | 61 | 54 | 115 |
| 2021 6 | 84 | 40 | 124 |
| 2021 5 | 81 | 71 | 152 |
| 2021 4 | 170 | 133 | 303 |
| 2021 3 | 109 | 62 | 171 |
| 2021 2 | 120 | 47 | 167 |
| 2020 1 | 102 | 27 | 129 |
| 2020 12 | 62 | 23 | 85 |
| 2020 11 | 52 | 34 | 86 |
| 2020 10 | 71 | 31 | 102 |
| 2020 9 | 64 | 36 | 100 |
| 2020 8 | 48 | 31 | 79 |
| 2020 7 | 60 | 41 | 101 |
| 2020 6 | 69 | 48 | 117 |
| 2020 5 | 54 | 34 | 88 |
| 2020 4 | 57 | 31 | 88 |
| 2020 3 | 63 | 15 | 78 |
| 2020 2 | 11 | 8 | 19 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 26 | 2 | 28 |
| 2019 11 | 46 | 17 | 63 |
| 2019 9 | 5 | 2 | 7 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 6 | 2 | 8 |
| 2019 6 | 11 | 2 | 13 |
| 2019 5 | 6 | 4 | 10 |
| 2019 4 | 16 | 7 | 23 |
| 2019 3 | 27 | 4 | 31 |
| 2019 2 | 11 | 8 | 19 |
| 2019 1 | 23 | 12 | 35 |
| 2018 12 | 78 | 2 | 80 |
| 2018 11 | 7 | 6 | 13 |
| 2018 10 | 19 | 9 | 28 |
| 2018 9 | 4 | 1 | 5 |
| 2018 8 | 1 | 4 | 5 |
| 2018 7 | 4 | 1 | 5 |
| 2018 6 | 1 | 1 | 2 |
| 2018 5 | 1 | 3 | 4 |
| 2018 4 | 2 | 4 | 6 |
| 2018 3 | 3 | 1 | 4 |
| 2018 2 | 44 | 6 | 50 |
| 2018 1 | 94 | 17 | 111 |
| 2017 12 | 68 | 15 | 83 |
| 2017 11 | 67 | 14 | 81 |
| 2017 10 | 51 | 9 | 60 |
| 2017 9 | 46 | 20 | 66 |
| 2017 8 | 49 | 20 | 69 |
| 2017 7 | 44 | 32 | 76 |
| 2017 6 | 49 | 23 | 72 |
| 2017 5 | 51 | 32 | 83 |
| 2017 4 | 85 | 28 | 113 |
| 2017 3 | 37 | 38 | 75 |
| 2017 2 | 47 | 78 | 125 |
| 2016 1 | 71 | 111 | 182 |
| 2016 12 | 7 | 39 | 46 |
| 2016 11 | 0 | 37 | 37 |
| 2016 10 | 0 | 58 | 58 |
| 2016 9 | 0 | 5 | 5 |
Mostrar todo
